CD79A and COVID-19: However, our goal was to evaluate the diagnostic performance of the IBMP ELISA IgA/IgM/IgG COVID-19 kit, and the commercial assays were only used to compare the ability of the IBMP kit to identify the disease in individuals who are positive for COVID-19.